BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dolomite Launches Novel Microfluidic Device for Advanced Cell Immobilization and Observation


12/7/2011 11:26:32 AM

Royston, UK (7th December 2011) – In collaboration with The Gurdon Institute (University of Cambridge), Dolomite, a world leader in the design and manufacture of microfluidic solutions, has introduced the Embryo Immobilisation Chip ideal for the immobilization and observation of embryos or cell aggregates of up to 150µm in diameter.

Live imaging of a large number of small non-adherent samples, for a long time and at high-resolution, has been very difficult to achieve due to movements of the sample during handling processes. Working closely with Bernhard Stauss and The Gurdon Institute, Dolomite has addressed these challenges by developing a novel glass microfluidic device, optimized for high-resolution imaging and high throughput experimentation.

Featuring over 250 well chambers, the Embryo Immobilisation Chip keeps samples in position throughout imaging as well as during mounting from the microscope, allowing observations to be carried out over a number of days. Once viewing is complete, users can easily retrieve samples from the device for further analysis, including fixation, staining or genotyping.

The microfluidic chip can be supplied with a Chip Interface which is compatible with a wide range of standard microscope stage inserts. Offering excellent chemical compatibility and access for optics, the Embryo Immobilisation Chip and Interface enable users to quickly locate and observe the area of interest.

For further information on Dolomite’s range of microfluidic chips as well as a complete portfolio of microfluidic products including chips, connectors/ interconnects, valves and custom devices please visit www.dolomite-microfluidics.com.

The Dolomite Centre Limited

Established in 2005 as the world’s first Microfluidic Application Centre, Dolomite focused on working with customers to turn their concepts for microfluidic applications into reality. Today, Dolomite is the world leader in solving microfluidic problems. With offices in the UK and US and distributors throughout the rest of the world, its clients range from universities developing leading-edge analytical equipment, to manufacturers of chemical, life sciences and clinical diagnostics systems.

Dolomite is pioneering the use of microfluidic devices for small-scale fluid control and analysis, enabling manufacturers to develop more compact, cost-effective and powerful instruments. By combining specialist glass, quartz and ceramic technologies with knowledge of high performance microfluidics, Dolomite is able to provide solutions for a broad range of application areas including environmental monitoring, clinical diagnostics, food and beverage, nuclear, agriculture, petrochemical, cosmetics, pharmaceuticals and chemicals. Furthermore Dolomite's in-house micro-fabrication facilities that include clean rooms and precision glass processing facilities allow to prototype and test all solutions rapidly which ensures a faster development cycle and reduces the time to market.

For more information please visit www.dolomite-microfluidics.com.

For more information on The Wellcome Trust/Cancer Research UK Gurdon Institute (University of Cambridge), please visit www.gurdon.cam.ac.uk



Read at BioSpace.com

Dolomite
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES